191 related articles for article (PubMed ID: 37900279)
1. Secretome analysis of breast cancer cells to identify potential target proteins of
Swami S; Mughees M; Mangangcha IR; Kauser S; Wajid S
Front Cell Dev Biol; 2023; 11():1247632. PubMed ID: 37900279
[No Abstract] [Full Text] [Related]
2. Identification of protein targets and the mechanism of the cytotoxic action of Ipomoea turpethum extract loaded nanoparticles against breast cancer cells.
Mughees M; Samim M; Sharma Y; Wajid S
J Mater Chem B; 2019 Oct; 7(39):6048-6063. PubMed ID: 31549130
[TBL] [Abstract][Full Text] [Related]
3. Secretome profiling of
Kauser S; Mughees M; Mangangcha IR; Swami S; Wajid S
Front Oncol; 2023; 13():1209168. PubMed ID: 37719007
[TBL] [Abstract][Full Text] [Related]
4. Cytotoxic potential of Artemisia absinthium extract loaded polymeric nanoparticles against breast cancer cells: Insight into the protein targets.
Mughees M; Wajid S; Samim M
Int J Pharm; 2020 Aug; 586():119583. PubMed ID: 32603837
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of acute oral toxicity of
Swami S; Mughees M; Kauser S; Wajid S
Front Pharmacol; 2023; 14():1086581. PubMed ID: 37007000
[No Abstract] [Full Text] [Related]
6. Evaluation of Cytotoxicity of Different Part Extracts of Ipomoea turpethum against Breast Cancer Cell Lines.
Mughees M; Wajid S
J Environ Pathol Toxicol Oncol; 2020; 39(1):51-60. PubMed ID: 32479012
[TBL] [Abstract][Full Text] [Related]
7. Correction: Identification of protein targets and the mechanism of the cytotoxic action of Ipomoea turpethum extract loaded nanoparticles against breast cancer cells.
Mughees M; Samim M; Sharma Y; Wajid S
J Mater Chem B; 2019 Nov; 7(43):6868. PubMed ID: 31659357
[TBL] [Abstract][Full Text] [Related]
8. Micro-RNA193a-3p Inhibits Breast Cancer Cell Driven Growth of Vascular Endothelial Cells by Altering Secretome and Inhibiting Mitogenesis: Transcriptomic and Functional Evidence.
Azzarito G; Kurmann L; Leeners B; Dubey RK
Cells; 2022 Sep; 11(19):. PubMed ID: 36230929
[TBL] [Abstract][Full Text] [Related]
9. PNIPAAm-MAA nanoparticles as delivery vehicles for curcumin against MCF-7 breast cancer cells.
Zeighamian V; Darabi M; Akbarzadeh A; Rahmati-Yamchi M; Zarghami N; Badrzadeh F; Salehi R; Mirakabad FS; Taheri-Anganeh M
Artif Cells Nanomed Biotechnol; 2016; 44(2):735-42. PubMed ID: 25819738
[TBL] [Abstract][Full Text] [Related]
10. Nano-delivery systems focused on tumor microenvironment regulation and biomimetic strategies for treatment of breast cancer metastasis.
Gu X; Gao Y; Wang P; Wang L; Peng H; He Y; Liu Y; Feng N
J Control Release; 2021 May; 333():374-390. PubMed ID: 33798666
[TBL] [Abstract][Full Text] [Related]
11. Platelet extracellular vesicles are efficient delivery vehicles of doxorubicin, an anti-cancer drug: preparation and in vitro characterization.
Wu YW; Lee DY; Lu YL; Delila L; Nebie O; Barro L; Changou CA; Lu LS; Goubran H; Burnouf T
Platelets; 2023 Dec; 34(1):2237134. PubMed ID: 37580876
[TBL] [Abstract][Full Text] [Related]
12. Secretome of tumor-associated leukocytes augment epithelial-mesenchymal transition in positive lymph node breast cancer patients via activation of EGFR/Tyr845 and NF-κB/p65 signaling pathway.
Elghonaimy EA; Ibrahim SA; Youns A; Hussein Z; Nouh MA; El-Mamlouk T; El-Shinawi M; Mostafa Mohamed M
Tumour Biol; 2016 Sep; 37(9):12441-12453. PubMed ID: 27329104
[TBL] [Abstract][Full Text] [Related]
13. Capsanthin-Loaded Micelles: Preparation, Characterization and
Shanmugham V; Subban R
Food Technol Biotechnol; 2022 Sep; 60(3):350-360. PubMed ID: 36320357
[TBL] [Abstract][Full Text] [Related]
14. Breast cancer cell secretome analysis to decipher miRNA regulating the tumor microenvironment and discover potential biomarkers.
Feser R; Opperman RM; Nault B; Maiti S; Chen VC; Majumder M
Heliyon; 2023 Apr; 9(4):e15421. PubMed ID: 37128318
[TBL] [Abstract][Full Text] [Related]
15. Transcriptomic and Functional Evidence That miRNA193a-3p Inhibits Lymphatic Endothelial Cell (LEC) and LEC + MCF-7 Spheroid Growth Directly and by Altering MCF-7 Secretome.
Azzarito G; Henry M; Rotshteyn T; Leeners B; Dubey RK
Cells; 2023 Jan; 12(3):. PubMed ID: 36766731
[TBL] [Abstract][Full Text] [Related]
16. Impact of the Cancer Cell Secretome in Driving Breast Cancer Progression.
Zahari S; Syafruddin SE; Mohtar MA
Cancers (Basel); 2023 May; 15(9):. PubMed ID: 37174117
[TBL] [Abstract][Full Text] [Related]
17. Thymoquinone Alterations of the Apoptotic Gene Expressions and Cell Cycle Arrest in Genetically Distinct Triple-Negative Breast Cancer Cells.
Adinew GM; Messeha SS; Taka E; Badisa RB; Antonie LM; Soliman KFA
Nutrients; 2022 May; 14(10):. PubMed ID: 35631261
[TBL] [Abstract][Full Text] [Related]
18. Optimum inhibition of MCF-7 breast cancer cells by efficient targeting of the macropinocytosis using optimized paclitaxel-loaded nanoparticles.
Al-Humaidi RB; Fayed B; Shakartalla SB; Jagal J; Jayakumar MN; Al Shareef ZM; Sharif SI; Noreddin A; Semreen MH; Omar HA; Haider M; Soliman SSM
Life Sci; 2022 Sep; 305():120778. PubMed ID: 35792181
[TBL] [Abstract][Full Text] [Related]
19. The secretome of non-tumorigenic mammary cells MCF-10A elicits DNA damage in MCF-7 and MDA-MB-231 breast cancer cells.
Vedoya GM; López Nigro MM; Martín GA
Toxicol In Vitro; 2021 Feb; 70():105018. PubMed ID: 33049311
[TBL] [Abstract][Full Text] [Related]
20. Nanoparticle-Mediated Targeted Drug Delivery to Remodel Tumor Microenvironment for Cancer Therapy.
Tang L; Mei Y; Shen Y; He S; Xiao Q; Yin Y; Xu Y; Shao J; Wang W; Cai Z
Int J Nanomedicine; 2021; 16():5811-5829. PubMed ID: 34471353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
